{
    "Trade/Device Name(s)": [
        "HemosIL\u00ae Protein S Activity"
    ],
    "Submitter Information": "Instrumentation Laboratory Co.",
    "510(k) Number": "K102164",
    "Predicate Device Reference 510(k) Number(s)": [
        "K053499"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GGP"
    ],
    "Summary Letter Date": "March 4, 2011",
    "Summary Letter Received Date": "March 7, 2011",
    "Submission Date": "July 28, 2010",
    "Regulation Number(s)": [
        "21 CFR 864.7290"
    ],
    "Regulation Name(s)": [
        "Test Qualitative and Quantitative Factor Deficiency"
    ],
    "Analyte Class(es)": [
        "coagulation",
        "hematology"
    ],
    "Analyte(s)": [
        "Protein S"
    ],
    "Specimen Type(s)": [
        "Citrated plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ACL TOP Family",
        "ACL TOP",
        "ACL TOP 500 CTS",
        "ACL TOP 700"
    ],
    "Method(s)/Technology(ies)": [
        "Functional clotting assay",
        "Automated coagulation functional assay"
    ],
    "Methodologies": [
        "Measurement of prothrombin time prolongation in the presence of human recombinant factor, phospholipids, calcium ions, and activated Protein C"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for HemosIL Protein S Activity assay for the quantitative determination of free Protein S in citrated plasma using ACL TOP Family analyzers.",
    "Indications for Use Summary": "Automated coagulation functional assay for the quantitative determination of free Protein S in human citrated plasma as an aid in the diagnosis of hereditary and acquired Protein S deficiency, on ACL TOP Family analyzers.",
    "fda_folder": "Hematology"
}